Clinical Benefit and Utility of Switching to Aripiprazole Once Monthly in Patients with Antipsychotic Polypharmacy or Long Acting Injectable Antipsychotics for Patients with Schizophrenia in Routine Practice: A Retrospective, Observation Study

OBJECTIVE: In a number of controlled clinical trials and naturalistic studies, aripiprazole once monthly (AOM) has been found to be effective and safe as acute and maintenance treatment options for schizophrenia. However, such clinical data have been presented in selected patient population (i.e., a...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Clin Psychopharmacol Neurosci
Main Authors: Pae, Chi-Un, Han, Changsu, Bahk, Won-Myong, Lee, Soo-Jung, Patkar, Ashwin A., Masand, Prakash S.
Formato: Artigo
Idioma:Inglês
Publicado em: Korean College of Neuropsychopharmacology 2021
Assuntos:
Original Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC8077057/
https://ncbi.nlm.nih.gov/pubmed/33888652
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.9758/cpn.2021.19.2.233
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados